Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George T Grossberg

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
The Journal of Clinical Psychiatry|August 26, 2003
Diagnosis and treatment of Alzheimer's diseaseGeorge T Grossberg
Missouri Medicine|February 16, 2011
Geriatric psychiatry--an emerging specialtyGeorge T Grossberg
CNS Spectrums|November 8, 2005
Rationalizing therapeutic approaches in Alzheimer's diseaseGeorge T Grossberg
International Psychogeriatrics|March 15, 2003
The ABC of Alzheimer's disease: behavioral symptoms and their treatmentGeorge T Grossberg
Current Therapeutic Research, Clinical and Experimental|June 20, 2014
Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying onGeorge T Grossberg
Current Medical Research and Opinion|October 22, 2005
Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's diseaseGeorge T Grossberg
Drugs & Aging|June 28, 2008
Impact of rivastigmine on caregiver burden associated with Alzheimer's disease in both informal care and nursing home settingsGeorge T Grossberg
Drugs & Aging|July 5, 2011
Combination therapy for Alzheimer's diseaseLaxeshkumar Patel, George T Grossberg
CNS Drugs|November 21, 2018
Impact of Antidepressant Use on the Trajectory of Alzheimer's Disease: Evidence, Mechanisms, and Therapeutic ImplicationsRita Khoury, George T Grossberg
Journal of Clinical Pharmacology|July 1, 2006
Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's diseaseHugo Geerts, George T Grossberg
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
The Journal of Clinical Psychiatry|August 26, 2003
Diagnosis and treatment of Alzheimer's diseaseGeorge T Grossberg
Missouri Medicine|February 16, 2011
Geriatric psychiatry--an emerging specialtyGeorge T Grossberg
CNS Spectrums|November 8, 2005
Rationalizing therapeutic approaches in Alzheimer's diseaseGeorge T Grossberg
International Psychogeriatrics|March 15, 2003
The ABC of Alzheimer's disease: behavioral symptoms and their treatmentGeorge T Grossberg
Current Therapeutic Research, Clinical and Experimental|June 20, 2014
Cholinesterase inhibitors for the treatment of Alzheimer's disease:: getting on and staying onGeorge T Grossberg
Current Medical Research and Opinion|October 22, 2005
Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's diseaseGeorge T Grossberg
Drugs & Aging|June 28, 2008
Impact of rivastigmine on caregiver burden associated with Alzheimer's disease in both informal care and nursing home settingsGeorge T Grossberg
Drugs & Aging|July 5, 2011
Combination therapy for Alzheimer's diseaseLaxeshkumar Patel, George T Grossberg
CNS Drugs|November 21, 2018
Impact of Antidepressant Use on the Trajectory of Alzheimer's Disease: Evidence, Mechanisms, and Therapeutic ImplicationsRita Khoury, George T Grossberg
Journal of Clinical Pharmacology|July 1, 2006
Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's diseaseHugo Geerts, George T Grossberg
Pageof 13